KURA

Kura Oncology Inc.

Price

$12.53

return (12m)

74.27%

p/e

-3.15

p/bv

19.28

DIVIDEND YIELD

0.00%

KURA price

Kura Oncology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KURA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.23%

3 months

12.58%

1 year

74.27%

2 years

-37.72%

5 years

-21.19%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals KURA

Valuation

P/E

-3.15

Sector -4.38

Industry -4.38

P/BV

19.28

Sector 2.02

Industry 2.02

P/Revenue (PSR)

12.09

Sector -4.40

Industry -4.40

EV/EBITDA

-6.21

Sector -263.09

Industry -263.09

EV/EBIT

-6.18

Sector -702.90

Industry -702.90

P/EBITDA

-3.18

Sector -4.39

Industry -4.39

P/EBIT

-3.16

Sector -4.73

Industry -4.73

P/Total Assets

1.59

Sector 1.49

Industry 1.49

P/Net Current Assets

46.49

Sector -11.70

Industry -11.70

P/Working Capital

2.12

Sector -3.19

Industry -3.19

EPS

-3.33

Sector -2.14

Industry -2.14

BVPS

0.54

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

99.34%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-323.96%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-325.73%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.04

Sector 0.03

Industry 0.03

Profitability

ROE

-612.80%

Sector -65.14%

Industry -65.14%

ROA

-50.49%

Sector -65.53%

Industry -65.53%

ROIC

-304.36%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.73

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.59

Sector -6.07

Industry -6.07

Net Debt / EBIT

7.55

Sector -8.26

Industry -8.26

Net Debt / Equity

-10.60

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.12

Sector -0.05

Industry -0.05

Equity/Assets

0.08

Sector 0.41

Industry 0.41

Liabilities/Assets

0.92

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

17.87%

Sector -

Industry -

Fundamentals KURA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
KURA Kura Oncology Inc.	$12.53	67.51%	0.00%	-3.15	19.28	-612.80%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KURA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kura Oncology

Kura Oncology Inc.

Average Investor10 user rating

4.0 (2 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

60

Employees

Kura Oncology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $933.61 million, with shareholders equity totaling $48.43 million.

The company employs approximately 60 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kura Oncology Inc. reported $77.23 million in revenue, generating net income of $-296.78 million.

Key financial metrics include a P/E ratio of -3.15, a price-to-book (P/B) ratio of 19.28, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KURA.

Market cap

$933.61 million

Net worth

$48.43 million

$48,430,000.00

Assets

$587.79 million

$587,790,000.00

Total Shares Outstanding

89.00 million

89,000,000

Average Daily Trading Volume

$1.61 million

$1,607,842.62

Sector

Health Care

Industry

Biotechnology

KURA

KURA revenue and profits

Financial Results KURA

DRAG THE FRAME TO SEE MORE DATA

KURA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Kura Oncology (KURA) today?

A cotação de Kura Oncology (KURA) hoje está em US$ 12.53, com uma variação de 74.27% em relação ao último ano. A cotação de Kura Oncology (KURA) iniciou o ano negociando na casa dos US$ 10.39 e hoje está em US$ 12.53. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Kura Oncology (KURA) e dados de ações do Ibovespa e mercados internacionais.

Quando Kura Oncology (KURA) paga dividendos?

Kura Oncology (KURA) não distribuiu dividendos no último ano.

Is Kura Oncology (KURA) a good investment?

Atualmente, Kura Oncology (KURA) está cotada a US$ 12.53, com um P/L de -3.15, representando um desvio de -484% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 74.27 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 74.27%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kura Oncology (KURA) stock?

Investir em ações de Kura Oncology (KURA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Kura Oncology (KURA) yield today?

A rentabilidade de Kura Oncology (KURA) foi de 16.23% no último mês, 74.27% no último ano e -21.19% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Kura Oncology (KURA) hoje, o investimento total seria de US$ 1,253.00, com base na cotação atual de US$ 12.53.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,183.60
Em 5 anos: US$ 987.49
Em 10 anos: US$ 1,253.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KURA

Kura Oncology Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KURA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING KURA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kura Oncology

Kura Oncology Inc.

United States

19 years

2015

60

PROFIT X PRICE KURA

Financial Results KURA

KURA cash flow

Asset, Revenue and Profit Growth - KURA

KURA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions